Franklin Genomic Advancements ETF
Cboe US · USDUnder normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.
Be the first to share your outlook and start the conversation with other investors in the HELX community.